Skip to content
HowShorted

Korro Bio, Inc. short interest in 2025

In 2025, Korro Bio, Inc.'s disclosed short interest ran from 8.02% of shares outstanding on 15 Jan 2025 to 11.75% on 31 Dec 2025, a change of +3.73 percentage points. The year's high was 15.74% on 15 Sep 2025 and its low 8.02% on 15 Jan 2025, averaging 11.42% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.27 days on 14 Feb 2025. Full history: Korro Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Korro Bio, Inc. in 2025

2025 in figures

Start of year
8.02% (15 Jan 2025)
End of year
11.75% (31 Dec 2025)
Change
+3.73 pp
High
15.74% (15 Sep 2025)
Low
8.02% (15 Jan 2025)
Average
11.42%
Highest days to cover
14.27 (14 Feb 2025)
SEC filings marked
8

Every report in 2025

Korro Bio, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20258.02%6.37
31 Jan 20258.40%12.50
14 Feb 20258.68%14.27
28 Feb 20258.90%11.72
14 Mar 20258.80%12.47
31 Mar 20259.42%6.4610-K filed, results (8-K)
15 Apr 202510.60%10.65
30 Apr 202511.25%8.47
15 May 202511.39%12.9010-Q filed, results (8-K)
30 May 202510.57%10.68
13 Jun 20259.86%3.07
30 Jun 202510.75%9.80
15 Jul 202511.73%10.33
31 Jul 202512.67%9.18
15 Aug 202513.22%8.3210-Q filed, results (8-K)
29 Aug 202512.83%9.56
15 Sep 202515.74%4.25
30 Sep 202514.59%5.76
15 Oct 202511.33%3.76
31 Oct 202512.37%5.88
14 Nov 202515.30%1.0010-Q filed, results (8-K)
28 Nov 202513.17%2.12
15 Dec 202512.73%2.56
31 Dec 202511.75%6.01

See also: Korro Bio, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.